Sulzbach, Germany

Gunter Muller


Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 82(Granted Patents)


Location History:

  • Sulzbach/Taunus, DE (1993)
  • Wiesbaden, DE (1998)
  • Sulzback a. Ts., DE (2009)
  • Sulzbach a Ts., DE (2011)
  • Sulzbach, DE (1997 - 2013)
  • Frankfurt-am-Main, DE (1995 - 2017)

Company Filing History:


Years Active: 1993-2017

where 'Filed Patents' based on already Granted Patents

16 patents (USPTO):

Title: Gunter Muller: Innovator in Insulin and Lipase Inhibitors

Introduction

Gunter Muller is a prominent inventor based in Sulzbach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin derivatives and enzyme inhibitors. With a total of 16 patents to his name, Muller has established himself as a key figure in medical innovation.

Latest Patents

Muller's latest patents include groundbreaking work on insulin derivatives that possess an extremely delayed time-action profile. This invention introduces novel insulin analogs characterized by specific features, such as an amidated basic amino acid residue at the B chain end and various substitutions in the insulin structure. Additionally, he has developed azole derivatives that serve as lipase and phospholipase inhibitors. These compounds are designed to treat conditions that benefit from their inhibitory effects on hormone-sensitive lipase, mimicking insulin's action in fat metabolism.

Career Highlights

Throughout his career, Gunter Muller has worked with notable companies, including Sanofi-Aventis Deutschland GmbH and Hoechst Aktiengesellschaft. His work in these organizations has allowed him to advance his research and contribute to significant pharmaceutical developments.

Collaborations

Muller has collaborated with esteemed colleagues such as Stefan Petry and Norbert Tennagels. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Gunter Muller is a distinguished inventor whose work in insulin and enzyme inhibitors has made a lasting impact on the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…